Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Irritable Bowel Syndrome, January 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 60 articles:
HTML format


 

Single Articles

  1. LORSCH ZS, Liddle RA
    Mechanisms and clinical implications of gut-brain interactions.
    J Clin Invest. 2026;136:e196346.
    PubMed    
    Abstract available

  2. ZHANG HM, Zhang Y, Luo GJ, Zhang AX, et al
    Human umbilical cord mesenchymal stem cells alleviated diarrhea-type irritable bowel syndrome by improving intestinal function.
    World J Stem Cells. 2025;17:112100.
    PubMed    
    Abstract available

  3. SHANG S, Liu Y, Bai QL, Zhang Z, et al
    Latent myofascial trigger point injection improves symptoms in functional gastrointestinal disorders.
    World J Gastrointest Surg. 2025;17:111359.
    PubMed    
    Abstract available

  4. VASSALOS CM, Koutelekos I, Vassalou E
    Assessment of Prevalence of Dientamoeba fragilis and Its Associated Factors Compared to Those of Giardia lamblia and Blastocystis sp. Among Greek Patients with Suspicion of Intestinal Parasitosis.
    Adv Exp Med Biol. 2026;1490:181-189.
    PubMed    
    Abstract available

  5. WU W, Qiu Y, Liang F, Lu W, et al
    Acupuncture and moxibustion in irritable bowel syndrome: a mechanistic exploration from heart rate variability to cardiac metabolism.
    Front Neurol. 2025;16:1716708.
    PubMed    
    Abstract available

  6. SZURA E, Poniewierka E
    Impact of physical activity and selected relaxation techniques on the quality of life of female patients with irritable bowel syndrome.
    Prz Gastroenterol. 2025;20:439-442.
    PubMed    
    Abstract available

  7. SINGH A, Singh R
    The gastrointestinal endothelin system: receptors, cellular actions, and involvement in gastrointestinal disorders.
    Prz Gastroenterol. 2025;20:372-381.
    PubMed    
    Abstract available

  8. BALLENA-CAICEDO J, Zuzunaga-Montoya FE, Valladolid-Sandoval LAM, Valladares-Garrido MJ, et al
    Prevalence of irritable bowel syndrome in medical students: a systematic review and meta-analysis.
    Front Med (Lausanne). 2025;12:1714085.
    PubMed    
    Abstract available

  9. CHIU YT, Lee FJ, Kuo CY, Yang PC, et al
    The Post-Cholecystectomy Gut Microbiota Follows a Time-Varying Change-A Pilot Study.
    JGH Open. 2025;9:e70329.
    PubMed    
    Abstract available

  10. LEPCZYNSKA M
    The interplay between Blastocystis and human gut microbiota.
    Ann Parasitol. 2025;71:171-184.
    PubMed    
    Abstract available

  11. CHAVHAN PKB, Sayeed MS, Saiyad SS, Shah MN, et al
    Lactose Intolerance in Irritable Bowel Syndrome: Prevalence, Subtype Correlations, and Clinical Predictors in an Indian Cohort.
    Cureus. 2025;17:e97697.
    PubMed    
    Abstract available

  12. PUSHADAPU VVSK, Srikar G
    Development and evaluation of chitosan-xanthan gum-based controlled release nanoparticles of mebeverine hydrochloride for targeted IBS therapy: in silico, in vitro, and in vivo investigations.
    Daru. 2025;34:6.
    PubMed    
    Abstract available

  13. POPA IV, Dranga M, Nedelciuc O, Mihai C, et al
    Artificial Intelligence Methods for the Differential Diagnosis of Irritable Bowel Syndrome and Inflammatory Bowel Disease: A Systematic Review.
    J Gastrointestin Liver Dis. 2025;34:510-514.
    PubMed    
    Abstract available

  14. MOU JJ, Xu L, Luo YF, Tao QF, et al
    Assessing the Efficacy and Safety of Multiple Drugs for IBS-C: A Systematic Review and Network Meta-Analysis.
    J Gastrointestin Liver Dis. 2025;34:503-509.
    PubMed    
    Abstract available

  15. DU Y, Xu H, Xiong J, Wang Z, et al
    Tracing Evolution of Hotspots and Frontiers: A Bibliometric Exploration of Acupuncture Therapy in Irritable Bowel Syndrome.
    J Multidiscip Healthc. 2025;18:8133-8152.
    PubMed    
    Abstract available

  16. SAHU SK, Nath P, Mallick B, Praharaj D, et al
    Pharmacotherapy for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Beyond Conventional Laxatives: A Narrative Review.
    Cureus. 2025;17:e97523.
    PubMed    
    Abstract available

  17. GUAGNOZZI D, Gonzalez-Castro AM, Zabana Y, Fernandez-Banares F, et al
    Integrated Multi-Omic Analysis Identifies Altered Colonic Brush Border Profile as a Key Feature of Microscopic Colitis.
    United European Gastroenterol J. 2026;14:e70156.
    PubMed    
    Abstract available

  18. MIDENFJORD I, Khadija M, Sundelin E, Trindade IA, et al
    Increased Disease Burden in Irritable Bowel Syndrome With Comorbid Conditions and Psychiatric Diagnoses in a Multinational European Cohort: Results From the DISCOvERIE Project.
    United European Gastroenterol J. 2026;14:e70157.
    PubMed    
    Abstract available

  19. CAI E, Kouznetsova VL, Tsigelny IF
    Metabolomics-Based Machine Learning Diagnostics of Post-Acute Sequelae of SARS-CoV-2 Infection.
    Metabolites. 2025;15:801.
    PubMed    
    Abstract available

  20. AL-MADHAGI H
    A Systems Biology and Drug Repositioning Approach for the Analysis of Mutual Genes Between Celiac Disease and Irritable Bowel Syndrome.
    Biomed Res Int. 2025;2025:8227229.
    PubMed    
    Abstract available

  21. SUN F, Li H, Gong B, Hui S, et al
    Investigating the Causal Relationship and Shared Genetic Basis Between Major Depression Disorder and Eight Types of Gastrointestinal Diseases.
    Genet Res (Camb). 2025;2025:6931243.
    PubMed    
    Abstract available

  22. HSU LH, Chou YP, Shen TL, Wieczorek D, et al
    Otilonium bromide exhibits novel antifungal activity against Candida albicans via regulating iron homeostasis.
    Virulence. 2026;17:2609407.
    PubMed    
    Abstract available

  23. TACK C, Van den Houte K, Besard L, Capiau L, et al
    A study on the utility of inflammatory biomarkers in primary care irritable bowel syndrome: a sub analysis of the DOMINO randomized trial.
    BMC Gastroenterol. 2025 Dec 23. doi: 10.1186/s12876-025-04494.
    PubMed    
    Abstract available

  24. DOWRICK JM, Roy NC, Carco C, James SC, et al
    Integrated multi-omic and symptom clustering reveals lower-gastrointestinal disorders of gut-brain interaction heterogeneity.
    Gut Microbes. 2026;18:2604871.
    PubMed    
    Abstract available

  25. PORCHIA DD, Wang Y, Zhou Z, Chen M, et al
    Cannabis use, microbial diversity and Dialister abundance in older adults with HIV: A cross-sectional study.
    HIV Med. 2025 Dec 22. doi: 10.1111/hiv.70180.
    PubMed    
    Abstract available

  26. PROSPERO L, Riezzo G, Laselva G, D'Attoma B, et al
    Somatization, psychological distress, and quality of life across fibromyalgia, irritable bowel syndrome, and their comorbid phenotype: a cross-sectional clinical comparison.
    Front Psychol. 2025;16:1709017.
    PubMed    
    Abstract available

  27. ELKALLA MA, Ali YG, Ewais MM, Taha AS, et al
    Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07861.
    PubMed    
    Abstract available

  28. VON MUHLENBROCK C, Aronsohn F, Quera R, Madrid AM, et al
    The role of dietary fiber in the gastrointestinal tract: when, how and why?
    Best Pract Res Clin Gastroenterol. 2025;79:102080.
    PubMed    
    Abstract available

  29. BIESIEKIERSKI JR
    Clinical utility of gluten restriction in gastrointestinal disorders: Evidence, practice, and reappraisal of non-coeliac gluten sensitivity.
    Best Pract Res Clin Gastroenterol. 2025;79:102086.
    PubMed    
    Abstract available

  30. BERSCHBACK M, Abber S, Smith J, Staller K, et al
    Avoidant/restrictive food intake disorder in disorders of gut-brain interaction.
    Best Pract Res Clin Gastroenterol. 2025;79:102078.
    PubMed    
    Abstract available

  31. VAN DEN HOUTE K
    Dietary approaches in functional bowel disorders.
    Best Pract Res Clin Gastroenterol. 2025;79:102077.
    PubMed    
    Abstract available

  32. BUTT MF, Reghefaoui MH, Benedict AS, Reghefaoui M, et al
    Irritable Bowel Syndrome in Inflammatory Bowel Disease: An Evidence-Based Practical Review.
    J Clin Med. 2025;15:116.
    PubMed    
    Abstract available

  33. CHOJNACKI C, Medrek-Socha M, Chojnacki J, Gasiorowska A, et al
    Multi-Strain Probiotic Improves Tryptophan Metabolism and Symptoms in Chronic Fatigue Syndrome Patients with Co-Occurring Irritable Bowel Syndrome: An Open-Label Pilot Study.
    Nutrients. 2026;18:174.
    PubMed    
    Abstract available

  34. RUTA F, Avram C, Mardale E, Maior R, et al
    Histamine-Producing Intestinal Dysbiosis and Its Role in Lower Urinary Tract Infections and Irritable Bowel Syndrome in Young Women.
    Nutrients. 2025;18:16.
    PubMed    
    Abstract available

  35. CADUNGOG MEGT, Tayo LL
    Microinflammation-Driven Gene Expression Dynamics in the Pathogenesis of Metabolic Disorders and Cancer.
    Biology (Basel). 2025;15:19.
    PubMed    
    Abstract available

  36. PENG F, Xu K, Ba Q, Bi H, et al
    Investigating the causal roles of cholesterol and triglyceride subfractions across lipoproteins in irritable bowel syndrome: a Mendelian randomization study.
    Metabol Open. 2025;29:100434.
    PubMed    
    Abstract available

  37. TAO QF, Hua C, Zhuo X, Mou JJ, et al
    Face-to-Face Versus Digital, Telephone-Delivered, and Self-Help Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Systematic Review and Bayesian Indirect Treatment Comparison Meta-Analysis.
    J Med Internet Res. 2026;28:e75833.
    PubMed    
    Abstract available

  38. KERCKHOVE N, Zerbib F, Chambaz M, Mion F, et al
    Ethosuximide and Irritable Bowel Syndrome-Related Abdominal Pain: A Randomized Clinical Trial.
    JAMA Netw Open. 2026;9:e2551368.
    PubMed    
    Abstract available

  39. BADWEI N, Abdelsalam A, Wassif GO, El-Din HES, et al
    Frequency and predictive role of intestinal parasitic infections with irritable bowel syndrome in Egyptian patients: a case-control study.
    Infection. 2026 Jan 8. doi: 10.1007/s15010-026-02724.
    PubMed    
    Abstract available

  40. ERLITA D, Shatri H, Fauzi A, Abdullah M, et al
    The Role of Probiotics in Depression and Quality of Life in Patients with Irritable Bowel Syndrome.
    Acta Med Indones. 2025;57:485-492.
    PubMed    
    Abstract available

  41. POSLUSNEY MS, Li Q, Buchler IP, Huang Y, et al
    Development of a Novel Benzodiazepine to Delineate Peripheral GABA-A Signaling Mechanisms in Visceral Pain Syndromes.
    Cell Mol Gastroenterol Hepatol. 2026 Jan 5:101704.
    PubMed    
    Abstract available

  42. DA COSTA PM, Nunes PIG, Ciurleo GCV, Junior JWLT, et al
    The Role of Extracellular Vesicles as Diagnostic Tools in Gut-Brain Axis Disorders.
    Mol Neurobiol. 2026;63:349.
    PubMed    
    Abstract available

  43. NAKANISHI T, Drueke TB, Kuragano T
    Mechanism of reduced intestinal phosphate absorption by tenapanor: a hypothesis.
    Clin Kidney J. 2025;19:sfaf375.
    PubMed    
    Abstract available

  44. LAMBIASE C, Rettura F, Sciume GD, Tedeschi R, et al
    Targeting gamma-aminobutyric acid pathways in irritable bowel syndrome: bridging central nervous system, enteric dysfunction, and the microbiota-gut-brain axis.
    Front Pharmacol. 2025;16:1677037.
    PubMed    
    Abstract available

  45. ALHAJAJI R, Alfahmi M, Alshareef EM, Salim AMK, et al
    Does amitriptyline help for irritable bowel syndrome pain management?: An updated systematic review and meta-analysis.
    Medicine (Baltimore). 2026;105:e46869.
    PubMed    
    Abstract available

  46. BRUNO A, Saccoccio V
    Improvement of Gastrointestinal Symptoms After Diastasis Recti Repair: A Prospective Study.
    Aesthetic Plast Surg. 2026 Jan 5. doi: 10.1007/s00266-025-05588.
    PubMed    
    Abstract available

  47. GASPERI M, Gerstenberger A, Naliboff B, Afari N, et al
    Exploring Sex Differences in Irritable Bowel Syndrome Prevalence, Environmental Risk, and Comorbidities: A Population-Based Cohort Study of Veterans.
    Clin Transl Gastroenterol. 2026 Jan 5. doi: 10.14309/ctg.0000000000000967.
    PubMed    
    Abstract available

  48. BALLENA-CAICEDO J, Valladolid-Sandoval LAM, Zuzunaga-Montoya FE, Vera-Ponce VJ, et al
    Global Prevalence of Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis.
    Gastroenterology Res. 2025;18:308-321.
    PubMed    
    Abstract available

  49. ZHENG NS, Bar N, Kuo B, Staller K, et al
    Research Communication: Healthcare Utilisation Patterns in Patients With Irritable Bowel Syndrome Across an Integrated Healthcare System.
    Aliment Pharmacol Ther. 2026;63:294-298.
    PubMed    
    Abstract available

  50. KHASAWNEH M, Goodoory VC, Ng CE, Ford AC, et al
    Stability of Classification Systems for Irritable Bowel Syndrome.
    Aliment Pharmacol Ther. 2025 Dec 25. doi: 10.1111/apt.70503.
    PubMed    
    Abstract available

  51. ALSAKARNEH S, Al Ta'ani O, Mahmoud MY, Syn WK, et al
    Comprehensive Risk Profile of Gastrointestinal and Extra Articular Comorbidities in Ehlers-Danlos Syndrome: A Propensity-Matched Analysis of 118,256 Individuals.
    Aliment Pharmacol Ther. 2025 Dec 23. doi: 10.1111/apt.70506.
    PubMed    
    Abstract available

  52. ZHANG M, Wellens J, Zhao J, Ji H, et al
    Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003833.
    PubMed    
    Abstract available

  53. CENTOR RM, Aziz I
    Annals On Call - Mediterranean Diet in the Management of Irritable Bowel Syndrome.
    Ann Intern Med. 2026 Jan 6:e2505558OC. doi: 10.7326/ANNALS-25-05558.
    PubMed    


  54. CHANG A, Shahrvini B, Oh J, Prajapati DP, et al
    Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09633.
    PubMed    
    Abstract available

  55. ANWAR DFF, Salma ZN, Oktaviani SD, Adiyatma FN, et al
    Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes.
    Eur J Gastroenterol Hepatol. 2025 Dec 24. doi: 10.1097/MEG.0000000000003074.
    PubMed    
    Abstract available

  56. CRISTOFORI F, Calabrese FM, De Angelis M, Francavilla R, et al
    Data over doubt: Clarifications on calcium butyrate efficacy in pediatric irritable bowel syndrome.
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70326.
    PubMed    


  57. VERMEIJDEN NK, Gordon M, Benninga M, Vlieger A, et al
    Analysis of "Calcium butyrate efficacy in pediatric irritable bowel syndrome".
    J Pediatr Gastroenterol Nutr. 2025 Dec 30. doi: 10.1002/jpn3.70328.
    PubMed    


  58. YOUNGINER ST, Westbrook A, Buzenski J, Dykes C, et al
    Health-related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial.
    J Pediatr Gastroenterol Nutr. 2026 Jan 4. doi: 10.1002/jpn3.70333.
    PubMed    
    Abstract available

  59. PASRICHA PJ, Talley NJ
    Functional Dyspepsia.
    N Engl J Med. 2026;394:166-176.
    PubMed    
    Abstract available

  60. HAMBERG LEVEDAHL K, Carlson M, Nilsson GP, Jakobsson Larsson B, et al
    Investigating instruments for evaluation of gastrointestinal burdens in patients with systemic mastocytosis: an exploratory multimethod study.
    Scand J Gastroenterol. 2025 Dec 21:1-10. doi: 10.1080/00365521.2025.2604778.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;